Fastende plasmaglucose er enten lig med eller lavere hos patienter, der behandles med EXUBERA sammenlignet med patienter, der udelukkende behandles med orale præparater.
Fasting plasma glucose was similar to or lower in patients using a regimen including EXUBERA compared to patients treated with oral lo agents alone.